Your browser doesn't support javascript.
loading
Characterizing biopersistence potential of the metabolite 5:3 fluorotelomer carboxylic acid after repeated oral exposure to the 6:2 fluorotelomer alcohol.
Kabadi, Shruti V; Fisher, Jeffrey W; Doerge, Daniel R; Mehta, Darshan; Aungst, Jason; Rice, Penelope.
Afiliação
  • Kabadi SV; FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America. Electronic address: Shruti.Kabadi@fda.hhs.gov.
  • Fisher JW; FDA/NCTR/DBT, 3900 NCTR Road, Jefferson, AR 72079, United States of America.
  • Doerge DR; FDA/NCTR/DBT, 3900 NCTR Road, Jefferson, AR 72079, United States of America.
  • Mehta D; FDA/NCTR/DBT, 3900 NCTR Road, Jefferson, AR 72079, United States of America.
  • Aungst J; FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.
  • Rice P; FDA/CFSAN/OFAS/DFCS, 5001 Campus Drive, HFS 275, College Park, MD 20740, United States of America.
Toxicol Appl Pharmacol ; 388: 114878, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31923437
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros de Fluorcarboneto Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polímeros de Fluorcarboneto Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Toxicol Appl Pharmacol Ano de publicação: 2020 Tipo de documento: Article